Pictet Asset Management (Switzerland)’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$25.3M Buy
2023
Q1
$26.5M Buy